Home > Income Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Revenue

    Back to Income Statement
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹760 Cr₹631 Cr₹513 Cr₹466 Cr₹428 Cr

What is the latest Revenue of WINDLAS BIOTECH ?

The latest Revenue ratio of WINDLAS BIOTECH is ₹760 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹760 Cr
Mar2024₹631 Cr
Mar2023₹513 Cr
Mar2022₹466 Cr
Mar2021₹428 Cr

How is Revenue of WINDLAS BIOTECH Trending?

Years Revenue % Change
Mar2025 ₹760 Cr
20.43
Mar2024 ₹631 Cr
22.97
Mar2023 ₹513 Cr
10.12
Mar2022 ₹466 Cr
8.96
Mar2021 ₹428 Cr -

Compare Revenue of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,596.4 Cr -2.7% -3.8% 12.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-2.7%

-3.8%

12.8%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses